Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomasAgnes Elias, Markus D Siegelin, Albert Steinmüller, et al.
JACC. Case Reports|September 5, 2025
Concurrent TTR and AL Amyloidosis: Diagnostic Challenges and Clinical ImplicationsKaran Wats, Rajshekhar Chakraborty, Mariela Navarro-Torres, et al.
Molecular Cancer Therapeutics|May 27, 2010
Global targeting of subcellular heat shock protein-90 networks for therapy of glioblastomaMarkus D Siegelin, Janet Plescia, Christopher M Raskett, et al.
Cancers|August 6, 2020
Epigenetic Targeting of Mcl-1 Is Synthetically Lethal with Bcl-xL/Bcl-2 Inhibition in Model Systems of GlioblastomaEnyuan Shang, Trang T T Nguyen, Chang Shu, et al.
Expert Opinion on Drug Discovery|July 18, 2017
Targeting intrinsic apoptosis and other forms of cell death by BH3-mimetics in glioblastomaGeorg Karpel-Massler, Chiaki Tsuge Ishida, Yiru Zhang, et al.
Molecular Cancer Research : MCR|April 24, 2014
PI3K and Bcl-2 inhibition primes glioblastoma cells to apoptosis through downregulation of Mcl-1 and Phospho-BADFresia Pareja, David Macleod, Chang Shu, et al.
Oncotarget|April 19, 2017
BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant gliomaChiaki Tsuge Ishida, Elena Bianchetti, Chang Shu, et al.
Cancers|June 12, 2019
Activation of LXR Receptors and Inhibition of TRAP1 Causes Synthetic Lethality in Solid TumorsTrang Thi Thu Nguyen, Chiaki Tsuge Ishida, Enyuan Shang, et al.
Biomedicines|September 12, 2019
Temozolomide and Other Alkylating Agents in Glioblastoma TherapyHannah Strobel, Tim Baisch, Rahel Fitzel, et al.
Scientific Reports|October 20, 2018
Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systemsEnyuan Shang, Yiru Zhang, Chang Shu, et al.
Pageof 9